Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme
<b>Purpose</b>: Glioblastoma multiforme (GBM) is a highly aggressive cancer with limited survival despite current treatments. Rising treatment costs highlight the importance of identifying more affordable therapeutic alternatives. A body of literature has shown that metformin has the potential to ac...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2026-02-01
|
| Σειρά: | Neurology International |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/2035-8377/18/3/40 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|